Suppr超能文献

住院患者中纤维蛋白原水平与晚期结直肠腺瘤的关系:一项回顾性病例对照研究。

Relationship between fibrinogen level and advanced colorectal adenoma among inpatients: A retrospective case-control study.

作者信息

Wang Huijie, Zheng Huanwei, Cao Xu, Meng Ping, Liu Jinli, Wang Zhichao, Zhang Teng, Zuo Haiying

机构信息

Department of Endoscopy, Shijiazhuang Traditional Chinese Medicine Hospital, Shijiazhuang, China.

Department of Gastroenterology, Shijiazhuang Traditional Chinese Medicine Hospital, Shijiazhuang, China.

出版信息

Front Med (Lausanne). 2023 Mar 16;10:1140185. doi: 10.3389/fmed.2023.1140185. eCollection 2023.

Abstract

OBJECTIVE

This study was to explore the relationship between fibrinogen and advanced colorectal adenoma among inpatients.

METHODS

From April 2015 to June 2022, 3738 participants (566 case subjects and 3172 control subjects) who underwent colonoscopies enrolled, and smooth curve fitting and logistic regression models were applied to explore the association between fibrinogen and advanced colorectal adenoma. In addition, sensitivity and subgroup analyses were performed to assess the stability of the results.

RESULTS

Compared with lower fibrinogen quantile 1 (< 2.4 g/L), the adjusted OR values for fibrinogen and advanced colorectal adenoma in quantile 2 (2.4-2.75 g/L), quantile 3 (2.76-3.15 g/L), and quantile 4 (≥3.16 g/L) were 1.03 (95% confidence interval [CI]: 0.76-1.41), 1.37 (95% CI: 1.01-1.85), and 1.43 (95% CI: 1.06-1.94), respectively. A linear relationship between fibrinogen and advanced colorectal adenoma was observed. Sensitivity and subgroup analyses showed stable results.

CONCLUSION

Complements the evidence that fibrinogen was positively associated with advanced adenomas, suggesting that fibrinogen may play a role in the adenoma-carcinoma sequence.

摘要

目的

本研究旨在探讨住院患者中纤维蛋白原与进展期大肠腺瘤之间的关系。

方法

2015年4月至2022年6月,纳入3738例接受结肠镜检查的参与者(566例病例组和3172例对照组),应用平滑曲线拟合和逻辑回归模型探讨纤维蛋白原与进展期大肠腺瘤之间的关联。此外,进行敏感性分析和亚组分析以评估结果的稳定性。

结果

与较低的纤维蛋白原四分位数1(<2.4 g/L)相比,纤维蛋白原四分位数2(2.4 - 2.75 g/L)、四分位数3(2.76 - 3.15 g/L)和四分位数4(≥3.16 g/L)时进展期大肠腺瘤的校正比值比(OR)值分别为1.03(95%置信区间[CI]:0.76 - 1.41)、1.37(95%CI:1.01 - 1.85)和1.43(95%CI:1.06 - 1.94)。观察到纤维蛋白原与进展期大肠腺瘤之间存在线性关系。敏感性分析和亚组分析显示结果稳定。

结论

补充了纤维蛋白原与进展期腺瘤呈正相关的证据,提示纤维蛋白原可能在腺瘤 - 癌序列中起作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c379/10061582/5366c7dbdf21/fmed-10-1140185-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验